The PneumoADIP Approach

The PneumoADIP team is a small, dedicated team based at the Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from GAVI, and its partner, The Vaccine Fund. PneumoADIP aims to achieve its goals through partnership with countries, donors, academia, international organizations, and industry. PneumoADIP coordinates its activities through a strategic alliance with WHO.

The PneumoADIP is organized around 3 main areas of activities:

1. Establishing the value of vaccination by demonstrating the burden of meningitis and pneumonia caused by pneumococcal bacteria and demonstrating the value of preventing it through vaccination.
2. Communicating the knowledge about disease burden and the value of vaccination by ensuring that research data are communicated effectively to key decision makers through appropriate and effective channels.
3. Delivering the value of the vaccine by ensuring that there is a predictable supply of quality vaccine at an affordable price, an adequate system to deliver it to the children who need it, and the financing to sustain its use.

Similar of The PneumoADIP Approach

Pneumococcal Disease

More children die each year from pneumonia than from any other infectious disease - even more than from malaria or AIDS - according to the World Health

Measles, Mumps and Rubella Vaccines (MMR)

Adverse Events After MMR Vaccination Adverse events associated with administration of MMR vaccine range from local pain, induration, and edema to rare systemic

Chicken Pox can be Prevented

Doctors in a seminar opined in favour of getting jab of Chicken Pox vaccine to avoid this infectious disease for those who are not yet exposed to the virus.

What are the Guidelines for Preventing Recurrent Acute Otitis Media

Antibiotics Antibiotics have been used for prevention of acute otitis media in children under the following circumstances: If the child has had three or more

Scientific Breakthrough in Malaria Vaccine Development

Researchers report that GSK Biologicals' RTS.S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria.

Diphtheria and Poliomyelitis

Specific Treatment Antitoxin. Once a case of diphtheria is suspected and a throat swab sent for bacterio-logical examination, diphtheria antitoxin serum should

The Sugar Season

The holiday season that is now upon us is a time for festivity, and usually of overeating. But the rampant consumption of sugar that marks this time of year is

Topics:

• Disease and Treatment